CX Institutional’s Hanesbrands HBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,841
Closed -$38K 1551
2025
Q3
$38K Hold
5,841
﹤0.01% 988
2025
Q2
$27K Hold
5,841
﹤0.01% 934
2025
Q1
$34K Buy
+5,841
New +$40.9K ﹤0.01% 890
2022
Q3
Sell
-5,841
Closed -$60K 751
2022
Q2
$60K Buy
+5,841
New +$72.6K ﹤0.01% 634
2021
Q4
Sell
-6,347
Closed -$109K 580
2021
Q3
$109K Buy
6,347
+59
+0.9% +$1.11K 0.01% 432
2021
Q2
$117K Sell
6,288
-480
-7% -$9.51K 0.01% 415
2021
Q1
$133K Buy
6,768
+78
+1% +$1.38K 0.01% 347
2020
Q4
$97K Sell
6,690
-2,579
-28% -$38.9K 0.01% 364
2020
Q3
$146K Sell
9,269
-813
-8% -$11.9K 0.02% 278
2020
Q2
$114K Sell
10,082
-1,550
-13% -$15.5K 0.02% 274
2020
Q1
$92K Sell
11,632
-55,969
-83% -$709K 0.02% 274
2019
Q4
$1M Buy
67,601
+5,333
+9% +$81.1K 0.18% 112
2019
Q3
$954K Sell
62,268
-61,269
-50% -$932K 0.15% 133
2019
Q2
$2.13M Buy
123,537
+116,921
+1,767% +$2.01M 0.34% 76
2019
Q1
$118K Sell
6,616
-40,641
-86% -$675K 0.02% 261
2018
Q4
$592K Sell
47,257
-93,342
-66% -$1.45M 0.13% 125
2018
Q3
$2.59M Buy
140,599
+9,934
+8% +$193K 0.86% 41
2018
Q2
$2.88M Buy
+130,665
New +$2.46M 1.06% 34

Other funds holding HBI

CX Institutional's HBI Position: Q4 2025 in Review

CX Institutional sold out of Hanesbrands (HBI) in Q4 2025, closing a stake of 5,841 shares — an estimated $38K sold.

CX Institutional first reported a position in HBI in Q2 2018 and held it in 18 quarters. The position peaked at $2.88M in Q2 2018. 2 funds tracked by Wall St. Rank hold HBI as of Q4 2025.

  • CX Institutional reported no remaining Hanesbrands position as of Q4 2025 after selling out during the quarter.
  • CX Institutional sold 5,841 Hanesbrands shares in Q4 2025, an estimated $38K.
  • CX Institutional first reported a position in Hanesbrands in Q2 2018 and held it in 18 quarters.
  • CX Institutional's Hanesbrands position peaked at $2.88M in Q2 2018.
  • 2 funds tracked by Wall St. Rank held Hanesbrands as of Q4 2025.

Based on CX Institutional's 13F filing for Q4 2025, filed 2 Feb 2026.